Form 4: Tenet Healthcare Director Receives Equity Grant

Director Richard J. Mark was granted 1,188 restricted stock units as part of the Tenet Healthcare Corporation stock incentive plan.

Summary

• Director Richard J. Mark received a grant of 1,188 restricted stock units (RSUs) on May 27, 2026.
• Each RSU represents the economic equivalent of one share of Tenet Healthcare common stock.
• The units are scheduled to vest on May 27, 2027, one year after the grant date.
• The reporting person retains the option to receive up to 37% of the vested units in cash rather than shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership and potential volatility in Tenet Healthcare stock price.

Future Outlook

The restricted stock units will vest on May 27, 2027, at which point the director will receive shares or a cash equivalent for up to 37% of the award.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practices designed to align director incentives with company performance in the healthcare services sector.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with compensation practices at peer healthcare organizations such as HCA Healthcare and Universal Health Services.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity incentive grant.

Next Steps

• Vesting of the restricted stock units on May 27, 2027.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Director Compensation, Restricted Stock Units, Insider Transaction